<META charset="Unicode">
<meta name="description" content="Risk Analysis (RA) is the process of identification of GMP-relevant risks and respective mitigation measures in connection to specific design/URS/process."/>
<html lang="en">
<head>
	<link rel="alternate" hreflang="ru" href="http://www.pharmagroup.ee/03_validation/02_ra_rus.html">
	<link rel="shortcut icon" href="../pics/pgb_icon_16-64.ico" type="image/x-icon">
	<title>RA | Pharma Group Baltic - Pharmaceutical Engineering, GMP-Consulting and Validation, GMP-Monitoring System Tarqvara® (EMS)</title>
</head>
<frameset rows="120,*">
	<frame src="../f_top.html" name="f_top" scrolling=no frameborder=0 framespacing=0 marginheight=0 noresize>
	<frameset cols="150,*" name="f_bottom">
		<frameset rows="60,*">
			<frame src="../f_left_top.html" name="f_left_top" scrolling=no frameborder=0 framespacing=0 marginheight=0 marginwidth=0 noresize>
			<frame src="../f_left_eng.html" name="f_left" scrolling=no frameborder=0 framespacing=0 marginheight=0 marginwidth=10 noresize>
		</frameset>
		<frame src="02_ra_eng_c.html" name="f_right" frameborder=0 framespacing=0 marginheight=0 marginwidth=0  noresize>
	</frameset>
	
	<noframes>
		<font face="Microsoft Sans Serif, Sans Serif, Arial" >
			<BR>
			<TABLE width=80% align=center>
				<TR>
					<TD>
						<font size=6 color=#100080><b>Risk Analyses (RA)</b></font><BR><BR>		
					</TD>
				</TR>
				<TR>
					<TD>		
						<img src="../pics/validation.png" align=right hspace=20 vspace=10>
						<font size=4 color=#8B8B8B>
						<p align=justify>
						Basic Risk Analysis (BRA) is conducted in the conceptual design stage of a project. In the course of a Basic Risk Analysis the production facility/department/area is considered as a whole entity, whereby a general GMP-compliance and risk analysis is performed for the developed hygienic zones concept (layout), material and personnel flows, process and auxiliary equipment, and the process itself.
						<p align=justify>
						Results of Basic Risk Analysis, first approved versions of layouts and a list of equipment are the basis for the preparation of Validation Master Plan (VMP) which defines the policy for qualification / validation activities, responsible persons, documentation format, equipment / systems to be qualified (Qualification Matrix) and processes / methods to be validated.
						<p align=justify>
						In the course of a Detailed Risk Analysis (RA) are considered in detail possible risks that are connected to individual systems or equipment units, and also compliance to GMP requirements of equipment design specifications provided by its manufacturer.
						<p><b>Pharma Group Baltic offers:</b></p>
						<ul>
							<img src=../bullet.png>Conducting Risk Analysis (GMP RA, FMEA, HAZOP)</img>
							<p><img src=../bullet.png>Assistance/support in Risk Analysis conduction by the Clients specialists</img>
							<p><img src=../bullet.png>Checking Risk Analysis conducted by the Clients specialists</img>
						</ul>
						</font>
					</TD>
				</TR>
			</TABLE>
		</font>
	</noframes>

</frameset>
</html>